Gastrinoma

This is a type of tumor, usually in the pancreas or duodenum, that makes too much of a hormone called gastrin. This hormone helps control stomach acid. Too much gastrin can cause severe stomach ulcers and other digestive issues.

Condition

What people with Gastrinoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Prilosec (Omeprazole) for Gastrinoma?

NameHow it went

About Gastrinoma

What It Is

A gastrinoma is a rare tumor that releases large amounts of gastrin, a hormone that tells the stomach to make acid. Normally the body releases a small amount of gastrin after a meal. A gastrinoma releases it constantly, so the stomach produces far more acid than it needs. The condition this causes is called Zollinger-Ellison syndrome. The extra acid leads to stomach and duodenal ulcers that are often severe or keep coming back, along with heartburn and acid reflux, burning pain in the upper abdomen, nausea and weight loss. Diarrhea is common and is sometimes the only symptom, because acid pouring into the small intestine disrupts digestion. Most gastrinomas grow in the duodenum (the first part of the small intestine) or the pancreas. Gastrinomas are a type of neuroendocrine tumor, and many are cancerous. When one spreads, it usually reaches nearby lymph nodes first and later the liver or bones. They tend to grow slowly, however, and many people live for many years after diagnosis.

Causes & Risk Factors

In most people, the cause of a gastrinoma is unknown. These sporadic cases are not inherited and make up roughly three quarters of all gastrinomas. The remaining 20 to 25 percent occur in people with multiple endocrine neoplasia type 1 (MEN1), an inherited disorder that causes tumors in several hormone-producing glands, including the parathyroid glands in the neck, the pituitary gland and the pancreas. People with MEN1 usually develop several small gastrinomas rather than one. Because MEN1 runs in families, a gastrinoma diagnosis often leads to questions about genetic testing for the person and their relatives. Zollinger-Ellison syndrome is most often diagnosed between ages 20 and 50 and is slightly more common in men.

How It's Diagnosed

Doctors usually suspect a gastrinoma when ulcers are severe, keep returning or cause complications, especially when the usual causes of ulcers (infection with the bacterium H. pylori or regular use of anti-inflammatory pain relievers such as ibuprofen) are absent. Chronic diarrhea alongside reflux or ulcers, or a personal or family history of MEN1, also raises suspicion. The first test measures gastrin in the blood after fasting. A high level points toward a gastrinoma only when the stomach is also making a lot of acid, so doctors often check the acidity of stomach fluid as well. This matters because other things raise gastrin too, including a stomach that makes too little acid and the acid-reducing medicines most people with ulcer symptoms are already taking. A secretin stimulation test can help settle unclear results: secretin, a hormone given through a vein, makes gastrinomas release more gastrin but has little effect on normal tissue. Those acid-reducing medicines create a real dilemma. Stopping them can make testing more accurate, but in someone who truly has a gastrinoma, stopping them abruptly can cause serious ulcer and reflux complications. Any change before testing should be planned by the specialist, and because the diagnosis leads to lifelong treatment, experts advise confirming it at a center experienced with these tumors. Once the diagnosis is made, imaging locates the tumor and checks for spread. This often includes CT or MRI, endoscopic ultrasound (an ultrasound probe passed on a thin tube through the mouth) and a specialized PET scan that highlights the hormone receptors most gastrinomas carry. Small duodenal tumors can still be hard to find.

Treatment Options

Treatment has two goals: controlling the excess acid, and dealing with the tumor itself. Acid control comes first. Proton pump inhibitors (PPIs), such as omeprazole (Prilosec) and pantoprazole (Protonix), sharply reduce the stomach's acid production, which relieves pain and diarrhea and lets ulcers heal. People with gastrinoma often need higher doses than are used for ordinary reflux, and many need a PPI for life, including some whose tumor has been removed. Long-term use can lower vitamin B12 levels, so this may be checked over time. For a sporadic gastrinoma that has not spread, surgery to remove it can cure the syndrome and prevent spread, so it is usually offered when the tumor can be found and removed safely. Cure is not possible in more than half of people, mainly because the disease has already spread or there are many tumors. In MEN1, tumors are typically numerous and small, so surgery is usually reserved for larger tumors, which are more likely to spread. When a gastrinoma has spread, treatment aims to slow its growth and control symptoms over the long term. Options include somatostatin analogs (injected medicines that mimic a natural hormone and can slow some neuroendocrine tumors), targeted cancer medicines such as everolimus or sunitinib, chemotherapy, and treatments aimed at liver tumors. Peptide receptor radionuclide therapy (PRRT), a radioactive medicine that travels to tumor cells carrying the same receptors seen on the PET scan, is another option for some people. Specialists differ on the best order of these treatments, so the plan is tailored to how fast the tumor is growing and where it has spread.

What to Expect

With effective acid control, most people's ulcers heal and their symptoms settle. Daily life then usually centers on taking the medicine consistently, since missed doses can let acid and symptoms return quickly. Because many people take a PPI for decades, the dose is reviewed periodically. Follow-up continues even after successful surgery, because gastrinomas can return or appear elsewhere. It typically includes periodic gastrin blood tests, imaging and, at times, endoscopy. People with MEN1 also need ongoing monitoring of the other glands the disorder affects. The outlook varies widely. Many gastrinomas grow slowly, and people can live for many years, even with some spread. Outcomes depend largely on whether the tumor has spread; on average, people with MEN1-related gastrinoma do better than those with sporadic gastrinoma, whose tumors more often spread to the liver. Because the condition is rare, care from a team experienced with neuroendocrine tumors can make a meaningful difference.

When to Seek Help

Ask about an evaluation if you have ulcers that are severe, keep coming back or occur without H. pylori infection or regular use of anti-inflammatory pain relievers, or if long-lasting diarrhea comes with heartburn or ulcer pain. A family history of MEN1 is also a reason to discuss testing. If you already have a gastrinoma, contact your care team promptly for persistent vomiting, difficulty or pain with swallowing, or ulcer symptoms that return or worsen despite your medicine. Do not stop or reduce your PPI without your specialist's plan. Get emergency care for vomiting blood or material that looks like coffee grounds, black or tarry stools, fainting or a racing pulse, or sudden, sharp abdominal pain that does not go away. These can signal a bleeding or perforated ulcer.

Questions to Ask Your Doctor

  1. 1.How sure are we that this is a gastrinoma, and should the diagnosis be confirmed at a center that specializes in these tumors?
  2. 2.Should I or my family members be tested for MEN1?
  3. 3.Has the tumor been located, and is surgery a realistic option to remove it?
  4. 4.What PPI dose will keep my acid under control, and how will we monitor its long-term effects?
  5. 5.What follow-up tests and scans will I need, and how often?

Last reviewed • Oct 2026

Educational content, not medical advice.